XTAI
4763
Market cap1.48bUSD
Sep 17, Last price
47.70TWD
1D
6.24%
1Q
7.67%
Jan 2017
-31.60%
IPO
-41.94%
Name
Jinan Acetate Chemical Co Ltd
Chart & performance
P/E
7.80
P/S
3.57
EPS
6.12
Div yield, %
5.24%
Shrs. gr., 5y
68.39%
Rev. gr., 5y
41.25%
Revenues
13.23b
-15.80%
Net income
6.05b
-27.44%
CFO
3.70b
-52.53%
Dividend
Sep 16, 20263.05 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jinan Acetate Chemical Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of cellulose acetate, acetate tows, acetic anhydride, diacetate fiber filament, diacetate fiber tow, and other related products in Asia, Europe, America, and Africa. The company also engages in investment activities. Its products are used in cigarette filters, fountain pen refills, and absorbent layers for diapers and masks. Jinan Acetate Chemical Co., Ltd. was founded in 1999 and is based in Grand Cayman, the Cayman Islands.
Key people
Chieh-Jui Chen
Chief Financial Officer, Corporate Governance Officer · since 2025
Ching-Li Meng
General Manager · since 2010
Ko-Chang Wang
Chairman of the Board, General Manager · since 2014
Ji-Qiang Liang
Deputy General Manager · since 2019
Zhen Liu
Deputy General Manager · since 2007
Ai-Feng Zhang
Deputy General Manager · since 2017
Jin-Po Zhao
Deputy General Manager-Finance Department · since 2015
Zhang-Chao Zhu
Deputy General Manager · since 2007
Chong'an Wang
Chief Information Security Officer · since 2022
Ericson Fensterseifer
Director · since 2014
Director · since 2014
Ching-Li Meng
Director · since 2020
Kuang-Chi Lee
Independent Director · since 2023
Wen-Cheng Lin
Independent Director · since 2014
Tzer-Jong Lin
Independent Director · since 2014
Ching-Hsien Yu
Independent Director · since 2019
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||